The clinical use of monoclonal antibodies directed against tumor associated antigens has been rapidly developed over the past few years. We report here our experience in detection of primary and metastatic sites of colorectal carcinoma using different radiolabelled monoclonal antibodies (MoAbs).
|Number of pages||2|
|Journal||Nuclear Medicine and Biology|
|Publication status||Published - 1989|
ASJC Scopus subject areas
- Cancer Research
- Molecular Medicine
- Radiology Nuclear Medicine and imaging